Showing 161 - 180 results of 22,459 for search '(((( ((b large) OR (i large)) decrease ) OR ( 19 cases increased ))) OR ( c larger decrease ))', query time: 1.95s Refine Results
  1. 161

    Data_Sheet_1_Stroke care during the COVID-19 pandemic: Case numbers, treatments, and mortality in two large German stroke registries.PDF by Alicia Brunssen (13136349)

    Published 2022
    “…</p>Conclusion<p>Case numbers slightly decreased under pandemic conditions, while our quarterly analysis indicated that the quality of stroke care was largely unchanged throughout the year 2020.…”
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173

    DataSheet_1_A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma.docx by Jeong-Yeon Cho (11787386)

    Published 2024
    “…Background<p>Approximately one-third of patients with diffuse large B-cell lymphoma (DLBCL) are refractory to treatment or experience relapse after initial therapy. …”
  14. 174
  15. 175

    Image2_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG by Chaofeng Zhang (845343)

    Published 2024
    “…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.…”
  16. 176

    Image_2_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg by Qikai Zhang (6905096)

    Published 2022
    “…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
  17. 177

    Image_4_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg by Qikai Zhang (6905096)

    Published 2022
    “…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
  18. 178

    Image_3_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg by Qikai Zhang (6905096)

    Published 2022
    “…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
  19. 179

    Supplementary Material for: STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma by Xiao S. (11834801)

    Published 2021
    “…However, the underlying mechanism of STAT3 in the pathogenesis of diffuse large B-cell lymphoma (DLBCL) has yet to be established. …”
  20. 180